Terry L. Smith
The University of Texas MD Anderson Cancer Center · 154 works · 21,114 citations · h-index 73
Top works
- A note on quantifying follow-up in studies of failure time
- Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
- Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
- Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer
- Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
- Combination chemotherapy in germinal cell tumors
- A computer program for estimating survival functions from the life table
- Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer
- Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteria
- Prognostic factors in acute leukemia.
- Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer
- Factors related to length of complete remission in adult acute leukemia
- High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia
- Is breast cancer survival improving?
- A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia
- Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
- Chronic myelogenous leukemia in blast crisis
- Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
- Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer